Clinical Trial Update: Efficacy and Safety of Adebrelimab Combined With Chemoradiotherapy in Patients With Unresectable Locally Advanced or Postoperative Recurrent Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Clinical trial update on the efficacy and safety of Adebrelimab with chemoradiotherapy in patients with unresectable locally advanced or postoperative recurrent…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Adebrelimab (adebrelimab)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING